Dr. Brian Artis has proposed a theory that nicotine can effectively compete with viral venoms for nicotinic acetylcholine receptors, potentially resolving long COVID symptoms. The theory suggests that nicotine has a higher binding affinity for these receptors than the spike protein or ivermectin. Anecdotal evidence from the early pandemic indicated that smokers and vapers appeared to have a lower incidence of severe COVID-19.
